{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:17:16Z","timestamp":1790889436621,"version":"4.1.0"},"reference-count":17,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2020,1,1]]},"DOI":"10.1001\/jamacardio.2019.4408","type":"journal-article","created":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T16:32:01Z","timestamp":1573662721000},"page":"38","source":"Crossref","is-referenced-by-count":10,"title":["Association of a P2Y<sub>12<\/sub> Inhibitor Copayment Reduction Intervention With Persistence and Adherence With Other Secondary Prevention Medications"],"prefix":"10.1001","volume":"5","author":[{"given":"Alexander C.","family":"Fanaroff","sequence":"first","affiliation":[{"name":"Penn Cardiovascular Outcomes, Quality and Evaluative Research Center, University of Pennsylvania, Philadelphia"},{"name":"Cardiovascular Medicine Division, University of Pennsylvania, Philadelphia"},{"name":"Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Peterson","sequence":"additional","affiliation":[{"name":"Department of Medicine, Duke University, Durham, North Carolina"},{"name":"Duke Clinical Research Institute, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Kaltenbach","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Cannon","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niteesh K.","family":"Choudhry","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts"},{"name":"Center for Healthcare Delivery Sciences (C4HDS), Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy D.","family":"Henry","sequence":"additional","affiliation":[{"name":"The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Anstrom","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Cohen","sequence":"additional","affiliation":[{"name":"University of Missouri\u2013Kansas City School of Medicine, Kansas City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"Fonseca","sequence":"additional","affiliation":[{"name":"AstraZeneca, BioPharmaceuticals Medical, Wilmington, Delaware"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naeem D.","family":"Khan","sequence":"additional","affiliation":[{"name":"AstraZeneca, BioPharmaceuticals Medical, Wilmington, Delaware"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg C.","family":"Fonarow","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Ronald Reagan\u2013UCLA Medical Center, Los Angeles, California"},{"name":"Associate Editor, JAMA Cardiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy Y.","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Medicine, Duke University, Durham, North Carolina"},{"name":"Duke Clinical Research Institute, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"4","key":"hoi190076r1","doi-asserted-by":"publisher","first-page":"e362","DOI":"10.1161\/CIR.0b013e3182742c84","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines.","volume":"127","author":"O\u2019Gara","year":"2013","journal-title":"Circulation"},{"issue":"24","key":"hoi190076r2","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","article-title":"2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines.","volume":"64","author":"Amsterdam","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"hoi190076r3","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/j.jacc.2016.12.005","article-title":"Trends in US cardiovascular care: 2016 report from 4 ACC national cardiovascular data registries.","volume":"69","author":"Masoudi","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"hoi190076r4","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ahj.2015.03.019","article-title":"Persistence with secondary prevention medications after acute myocardial infarction: insights from the translate-ACS study.","volume":"170","author":"Mathews","year":"2015","journal-title":"Am Heart J"},{"issue":"20","key":"hoi190076r5","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1161\/CIRCULATIONAHA.117.029160","article-title":"Hospital variation in adherence rates to secondary prevention medications and the implications on quality.","volume":"137","author":"Mathews","year":"2018","journal-title":"Circulation"},{"issue":"7","key":"hoi190076r6","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1001\/jamacardio.2016.2724","article-title":"Treatment, outcomes, and adherence to medication regimens among dual Medicare-Medicaid\u2013eligible adults with myocardial infarction.","volume":"1","author":"Doll","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"12","key":"hoi190076r7","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1161\/CIRCULATIONAHA.109.904003","article-title":"Medication adherence in cardiovascular disease.","volume":"121","author":"Baroletti","year":"2010","journal-title":"Circulation"},{"issue":"3","key":"hoi190076r8","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1377\/hlthaff.2012.1018","article-title":"Insurance expansion in Massachusetts did not reduce access among previously insured Medicare patients.","volume":"32","author":"Joynt","year":"2013","journal-title":"Health Aff (Millwood)"},{"key":"hoi190076r9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ahj.2016.04.008","article-title":"Rationale and design of the Affordability and Real-World Antiplatelet Treatment Effectiveness after Myocardial Infarction Study (ARTEMIS): a multicenter, cluster-randomized trial of P2Y12 receptor inhibitor copayment reduction after myocardial infarction.","volume":"177","author":"Doll","year":"2016","journal-title":"Am Heart J"},{"issue":"1","key":"hoi190076r10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1001\/jama.2018.19791","article-title":"Effect of medication co-payment vouchers on P2Y12 inhibitor use and major adverse cardiovascular events among patients with myocardial infarction: the ARTEMIS randomized clinical trial.","volume":"321","author":"Wang","year":"2019","journal-title":"JAMA"},{"issue":"4","key":"hoi190076r11","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1097\/SLA.0000000000002368","article-title":"Impact of the Hospital Readmission Reduction Program on surgical readmissions among medicare beneficiaries.","volume":"266","author":"Ibrahim","year":"2017","journal-title":"Ann Surg"},{"issue":"22","key":"hoi190076r12","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1056\/NEJMsa1107913","article-title":"Full coverage for preventive medications after myocardial infarction.","volume":"365","author":"Choudhry","year":"2011","journal-title":"N Engl J Med"},{"issue":"2","key":"hoi190076r13","doi-asserted-by":"publisher","first-page":"224","DOI":"10.2105\/AJPH.2017.304176","article-title":"Cost-related medication nonadherence for older adults participating in snap, 2013-2015.","volume":"108","author":"Srinivasan","year":"2018","journal-title":"Am J Public Health"},{"issue":"8","key":"hoi190076r14","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1176\/appi.ajp.2007.07010007","article-title":"Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs.","volume":"164","author":"Valuck","year":"2007","journal-title":"Am J Psychiatry"},{"issue":"6","key":"hoi190076r15","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.jhealeco.2013.01.001","article-title":"Pharmaceutical advertising and medicare part d.","volume":"32","author":"Lakdawalla","year":"2013","journal-title":"J Health Econ"},{"issue":"3","key":"hoi190076r16","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1177\/0969141317718220","article-title":"Spillover improved survival in non-invited patients of the colorectal cancer screening programme.","volume":"25","author":"Miettinen","year":"2018","journal-title":"J Med Screen"},{"issue":"23","key":"hoi190076r17","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1056\/NEJMp1806260","article-title":"Toward precision policy\u2014the case of cardiovascular care.","volume":"379","author":"Wadhera","year":"2018","journal-title":"N Engl J Med"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2754761\/jamacardiology_fanaroff_2019_oi_190076.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,15]],"date-time":"2020-01-15T17:24:26Z","timestamp":1579109066000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2754761"}},"subtitle":["A Post Hoc Analysis of the ARTEMIS Cluster-Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2020,1,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2019.4408","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1,1]]}}}